Novo Nordisk is facing serious pressure from a powerful adversary. It still has plenty of leeway to penetrate its target market, for now. Investors should keep a close eye on this company.

Trump added Denmark to his growing list of tariff targets — including Canada, Mexico and China — as he has increasingly ...